Multimode degradable hydrogels for controlled release of cargo substances

US10172938B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-10172938-B2
Application numberUS-201515307701-A
CountryUS
Kind codeB2
Filing dateApr 28, 2015
Priority dateApr 28, 2014
Publication dateJan 8, 2019
Grant dateJan 8, 2019

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

A responsive hydrogel-based material may be used as a carrier system for the in situ delivery of various cargo substances, including bioactive moieties. The hydrogel structure, which includes photodegradable and thioether moieties in its three dimensional network, enables finely tuned local release of cargo substances as a function of the in vivo tissue environment (e.g., enzyme concentration or reducing environment) and externally applied stimuli (e.g., light) by selective spatiotemporal hydrogel degradation.

First claim

Opening claim text (preview).

What is claimed is: 1. A hydrogel comprising a three-dimensional network of polymeric segments, wherein the polymeric segments are linked together, at least in part, by at least one photodegradable moiety and at least one thioether-containing moiety obtained by reaction of a thiol with an α,β-unsaturated carbonyl functional group which is a maleimide functional group. 2. The hydrogel of claim 1 , comprising a first polymeric segment which is linked to a second polymeric segment through a multimode degradable linkage comprised of a photodegradable moiety and a thioether-containing moiety obtained by reaction of a thiol with an α,β-unsaturated carbonyl functional group which is a maleimide functional group. 3. The hydrogel of claim 2 , wherein the multimode degradable linkage is additionally comprised of a hydrolyzable ester or amide moiety. 4. The hydrogel of claim 1 , wherein the polymeric segments include polyoxyalkylene-containing segments. 5. The hydrogel of claim 1 , wherein the polymeric segments include polymeric segments selected from the group consisting of polyether-containing segments, polypeptide-containing segments, polysaccharide-containing segments and combinations thereof. 6. The hydrogel of claim 1 , wherein the at least one photodegradable moiety includes at least one photodegradable moiety selected from the group consisting of nitro-substituted benzyl ester moieties and nitro-substituted benzyl amide moieties. 7. The hydrogel of claim 1 , wherein the at least one photodegradable moiety includes at least one photodegradable moiety containing an ester or amide linkage in the backbone of the three-dimensional network that undergoes irreversible cleavage upon being irradiated with UV, visible or IR light. 8. The hydrogel of claim 1 , wherein the at least one photodegradable moiety includes at least one photodegradable moiety having the general structure —Ar(NO 2 )—CHR′—Z—C(═O)—, wherein Ar is an aromatic moiety substituted with a nitro group ortho to —CHR′—, Z is O or NH, and R′ is H or alkyl. 9. The hydrogel of claim 1 , wherein the polymeric segments are additionally linked together by at least one hydrolyzable moiety. 10. The hydrogel of claim 9 , wherein the at least one hydrolyzable moiety includes at least one enzymatically-hydrolyzable moiety. 11. The hydrogel of claim 1 , wherein the at least one thioether-containing moiety includes at least one thioether-containing moiety capable of undergoing a thiol exchange reaction. 12. The hydrogel of claim 11 , wherein the at least one thioether-containing moiety capable of undergoing a thiol exchange reaction has the structural formula -A-S—R— where A is an aryl moiety or a heteroaromatic ring moiety and R is a succinimide moiety, the S being covalently bound to a carbon atom of the succinimide moiety. 13. The hydrogel of claim 1 , wherein the thiol is an arylthiol. 14. The hydrogel of claim 1 , wherein the polymeric segments are linked together, at least in part, by at least one moiety comprising structure (II): —O—Ar—CH(R′)—Z—C(═O)—(CH 2 ) 2 —C(═O)NH—(CH 2 ) 2 —R″—S—  (II) wherein Ar is a nitro-substituted aromatic ring, R′ is H or alkyl, Z is O or NH, R″ is a succinimide moiety having a nitrogen atom covalently bonded to —(CH 2 ) 2 —, and S is covalently bound to R″ through a carbon atom of the succinimide moiety. 15. The hydrogel of claim 1 , wherein the polymeric segments of the hydrogel are linked together, at least in part, by at least one moiety comprising structure (III): —O—Ar—CH(R′)—Z—C(═O)—(CH 2 ) 2 —C(═O)NH—(CH 2 ) p —Ar′—S—R″—  (III) wherein Ar is a nitro-substituted aromatic ring, R′ is H or alkyl, Z is O or NH, Ar′ is an aromatic ring, p is an integer of 1 or more, R″ is a succinimide moiety, and S is covalently bound to R″ through a carbon atom of the succinimide moiety. 16. A composition, comprising the hydrogel of claim 1 with at least one cargo substance encapsulated therein and/or covalently bound to the three-dimensional network of the hydrogel. 17. The composition of claim 16 , wherein the at least one cargo substance includes at least one bioactive substance. 18. The composition of claim 17 , wherein the bioactive substance is selected from the group consisting of small molecule drugs, biomolecules, biomacromolecules and cells. 19. The composition of claim 16 , wherein the cargo substance is a polymeric or inorganic particle. 20. The composition of claim 16 , wherein the at least one cargo substance includes a cargo substance which is physically retained within the hydrogel. 21. The composition of claim 16 , wherein the at least one cargo substance includes a cargo substance which is covalently bound to the three-dimensional network of the hydrogel. 22. A method of delivering a cargo substance to a subject in need thereof, wherein the method comprises administering a composition in accordance with claim 16 to the subject. 23. The method of claim 22 , additionally comprising exposing at least a portion of the composition to light following administration of the composition to the subject. 24. The method of claim 22 , wherein the composition is administered by injection, topical administration or implantation. 25. A method of making a hydrogel, wherein the method comprises reacting a functionalized polymer bearing at least x functional groups X with a functionalized linker molecule bearing at least y functional groups Y, wherein a) x and y are each independently an integer of 2 or more and x+y is an integer of 5 or more; b) X and Y are different from each other and are selected from the group consisting of maleimide and thiol, wherein one of X or Y is a malemide and one of X or Y is a thiol; c) at least one of the functionalized polymer or the functionalized linker molecule has a backbone containing at least one photodegradable moiety; and d) X and Y react to form a thioether linkage. 26. The method of claim 25 , wherein the functionalized polymer is a functionalized polyether, functionalized polypeptide or functionalized polysaccharide. 27. The method of claim 25 , wherein the photodegradable moiety includes at least one photodegradable moiety selected from the group consisting of nitro-substituted benzyl ester moieties and nitro-substituted benzyl amide moieties. 28. The method of claim 25 , wherein the at least one photodegradable moiety includes at least one photodegradable moiety containing an ester or amide linkage that undergoes irreversible cleavage upon being irradiated with UV, visible or IR light. 29. The method of claim 25 , wherein X and Y are selected from the group consisting of maleimide and arylthiol. 30. The method of claim 25 , wherein the functionalized linker molecule is a polyether, polypeptide or polysaccharide bearing at least y functional groups Y. 31. The method of claim 25 , wherein the functionalized polymer or the functionalized linker molecule corresponds to structure (I): R[—CH 2 CH 2 O) n —(CH 2 ) 2 NHC(═O)—(CH 2 ) 3 O—Ar—CH(R′)—Z—C(═O)—(CH 2 ) 2 —C(═O)NH—(CH 2 ) 2 -MI] m   (I) wherein R is an organic moiety, n is an integer of 2 or more, Ar is a nitro-substituted aromatic ring, R′ is H or alkyl, Z is O or NH, MI is a maleimide moiety having a nitrogen atom covalently bonded to —(CH 2 ) 2 — and m is an integer of 2 or more. 32. The method of claim 25 , whe

Assignees

Inventors

Classifications

  • by ultraviolet [UV] or infrared [IR] light, X-rays or gamma rays · CPC title

  • A61K47/10Primary

    Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers · CPC title

  • Ointments; Bases therefor; {Other semi-solid forms, e.g. creams, sticks, gels (composition of ointments, creams or gels A61K47/00)} · CPC title

  • End-capping · CPC title

  • Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers (A61K47/10 takes precedence) · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US10172938B2 cover?
A responsive hydrogel-based material may be used as a carrier system for the in situ delivery of various cargo substances, including bioactive moieties. The hydrogel structure, which includes photodegradable and thioether moieties in its three dimensional network, enables finely tuned local release of cargo substances as a function of the in vivo tissue environment (e.g., enzyme concentration o…
Who is the assignee on this patent?
Kiick Kristi L, Kloxin April M, Kharkar Prathamesh M, and 4 more
What technology area does this patent fall under?
Primary CPC classification A61K47/10. Mapped technology areas include Human Necessities.
When was this patent published?
Publication date Tue Jan 08 2019 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 1 related publication on this page (citations in our corpus or others sharing the same primary CPC).